Journals / Erciyes Tıp Dergisi / 2013 / Cilt: 35 - Sayı: 4

Mezenkimal kök hücre ile tedavi edilen kronik periton diyalizindeki ratlarda oksidan-antioksidan durum

Oxidant-antioxidant status of rats treated with mesenchymal stem cells in chronic peritoneal dialysis

Pages
224–228
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It cannot be said that this effect occurs via an antioxidant defense system according to the results of our study.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the present study was to investigate the effects of mesenchymal stem cell (MSC) transplantation on the oxidant-antioxidant system in rat models of chronic peritoneal dialysis (PD).
📊
Key Findings & Data:Material and Methods: A total of 50 Wistar albino male rats were used.
💡
Conclusion & Impact:It cannot be said that this effect occurs via an antioxidant defense system according to the results of our study.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of the present study was to investigate the effects of mesenchymal stem cell (MSC) transplantation on the oxidant-antioxidant system in rat models of chronic peritoneal dialysis (PD). Material and Methods: A total of 50 Wistar albino male rats were used. All rats were given PD fluid intraperitoneally once daily during six weeks. Then, rats were divided into five groups: PD, MSC-2, placebo-2, MSC-3 and placebo-3 groups. The MSC group was treated with MSC while the placebo group was treated with phosphate buffer solution via intraperitoneal injection. Placebo and MSC groups were evaluated at the second and third week of treatment. At the end of the study, peritoneum samples were taken from all rats under anesthesia. Glutathione peroxidase (GPx) and superoxide dismutase (SOD) activities and malondialdehyde (MDA) levels were studied in samples. Submesothelial thickness was measured. Results: Submesothelial thickness was significantly increased in PD and placebo groups compared with the MSC group. There were no statistical differences between PD with placebo and MSC groups in terms of MDA concentrations. Activities of antioxidant enzymes in MSC and P groups were lower than the PD group. Conclusion: MSC transplantation has a beneficial effect on the peritoneal membrane. It cannot be said that this effect occurs via an antioxidant defense system according to the results of our study.

Özet

Amaç: Bu çalışmada kronik periton diyaliz (PD) modelinde mezenkimal kök hücreler (MKH) naklinin oksidan-antioksidan sistem üzerine etkisinin değerlendirilmesi amaçlandı. Gereç ve Yöntemler: Çalışmada toplam 50 Wistar albino erkek rat kullanıldı. Tüm ratlara PD sıvısı intraperitoneal (ip) yolla 6 hafta süresince günde bir defa verildi. Daha sonra ratlar 5 gruba ayrıldı: PD, plasebo-2, MKH-2, plasebo-3 ve MKH-3 grupları. MKH gruplarına MKH, plasebo gruplarına ise fosfat tampon çözeltisi ip yolla verildi. PD grubundaki ratlarda hemen, plasebo ve MKH gruplarında ise tedaviyi takip eden 2. ve 3. haftalarda periton dokuları elde edildi. Bu örneklerde glutatyon peroksidaz (GPx), superoksid dismutaz (SOD) aktiviteleri ve malondialdehit (MDA) düzeyleri ölçüldü ve submezotelyal kalınlık değerlendirildi. Bulgular: Submezotelyal kalınlık, PD ve plasebo gruplarında MKH gruplarına kıyasla belirgin olarak artmıştı. MDA düzeyi plasebo ve MKH gruplarında PD grubu ile kıyaslandığında istatistiksel fark bulunmadı. Antioksidan enzimlerin aktiviteleri ise plasebo ve MKH gruplarında PD grubuna göre düşük bulundu. Sonuç: MKH naklinin periton zarı üzerinde olumlu sonuçları vardır. Çalışmamızın sonuçlarına göre bu etkinin antioksidan defans sistemi aracılığıyla olduğu söylenemez.

🔖

Cite This Article

ÇETİN, E., DÜŞÜNSEL, R., GÜNDÜZ, Z., POYRAZOĞLU, M. H., TÜLPAR, S., BAŞTUĞ, F., TORUN, Y., KAYA, E., ÖZBİLGE, H., AKGÜN, H., DÜDÜKCÜ, M. (2022). Mezenkimal kök hücre ile tedavi edilen kronik periton diyalizindeki ratlarda oksidan-antioksidan durum. Erciyes Tıp Dergisi, Cilt: 35 - Sayı: 4, 224–228. https://ajindex.com/articles/502406

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Kim Yl. Update on mechanisms of ultrafiltration failure. Perit Dial Int 2009; 29: 123-7
  2. Yung S, Chan TM. Mesothelial Cells. Perit Dial Int 2007; 27: 110-5
  3. Hjelle JT, Miller-Hjelle MA, Dobbie JW. The biology of the mesothelium during peritoneal dialysis. Perit Dial Int 1995; 15(7 Suppl): 13-22
  4. Saxena R. Pathogenesis and treatment of peritoneal membrane failure. Pediatr Nephrol 2008; 23(5): 695-703. [CrossRef] 5. Alhamdani MS. Impairment of glutathione biosynthetic patway in uremia and dialysis. Nephrol Dial Transplant 2005; 20(1): 124-8. [CrossRef] 6. Gotloib L. Mechanisms of cell death during peritoneal dialysis. A role for osmotic and oxidative stress. Contrib Nephrol 2009; 163: 35- 44. [CrossRef] 7. Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells. Stem Cells 2004; 22(4): 487-500. [CrossRef] 8. Bruder SP Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997; 64(2): 278-94. [CrossRef] 9. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992; 13(1): 81-8. [CrossRef] 10. Pittenger MF Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284(5411): 143-7. [CrossRef] 11. Newman RE, Yoo D, LeRoux MA, Danilkovitch-Miagkova A. Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets 2009; 8: 110-23. [CrossRef] 12. Valle-Prieto A, Conget PA. Human mesenchymal stem cells efficiently ma- nage oxidative stress. Stem Cells Dev 2010; 19(12): 1885-93. [CrossRef] 13. Tülpar S, Poyrazoğlu MH, Özbilge H, Baştuğ F Gündüz Z, Torun YA, et al. Modulation of inflammation by mesenchymal stem cell transplantation in peritoneal dialysis in rats. Ren Fail 2012; 34(10): 1317-23. [CrossRef] 14. Ueno T, Nakashima A, Doi S, Kawamoto T, Honda K, Yokoyama Y, et al. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling. Kidney Int 2013; 84(2): 297-307. [CrossRef] 15. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxidase in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95(2): 351-8. [CrossRef] 16. Schilte MN, Celie JW, Wee PM, Beelen RH, van den Born J. Factors contributing to peritoneal tissue remodeling